Factors Affecting the Response to Exercise in Patients with Severe Pulmonary Arterial Hypertension;Factores determinantes de la capacidad de ejercicio en pacientes con hipertensión arterial pulmonar severa

Archivos de Bronconeumologia

Volumn 47, Issue 1, 2011, Pages 10-16

  Flox Camacho, Ángela ^a   Escribano Subías, Pilar ^a   Jiménez López Guarch, Carmen ^a   Fernández Vaquero, Almudena ^b   Martín Ríos, Dolores ^c   Calzada Campo, Carlos Sáenz de la ^a  

^a MINISTERIO DE SANIDAD Y CONSUMO   (Spain)

^b UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^c HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

Author keywords

Echocardiography; Ergospirometry; Natriuretic peptides; Pulmonary arterial.hypertension

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; CARBON DIOXIDE; OXYGEN;

ADULT; AEROBIC CAPACITY; ANAEROBIC THRESHOLD; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE SIZE; HUMAN; LUNG PRESSURE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PULMONARY HYPERTENSION; SEX DIFFERENCE; SPIROMETRY; ANAEROBIC CAPACITY; CONTROLLED STUDY; HEART RIGHT VENTRICLE FAILURE; OXYGEN CONSUMPTION;

EID: 78751704448     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbres.2010.07.013     Document Type: Article

References (23)

1. Galiè N., Hoeper M., Humbert M., Torbicki A., Vachiery Jl., Barberá J.A., et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2009, 30:2493-2537.
2. Oudiz R.J. The role of exercise testing in the management of pulmonary arterial hypertension. Sem Resp Crit Car Med 2005, 26:379-384.
3. Raphael C., Briscoe C., Davis J., Whinnet Z.I., Manisty C., Sutton R., et al. Limitations of New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 2007, 93:476-482.
4. Guazzi M., Opasich C. Functional evaluation of patients with chronic pulmonary hypertension. Ital Heart J 2005, 6:789-794.
5. Miyamoto S., Nagaya N., Satoh T., Kyotani S., Sakamaki F., Fujita M., et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Am J Respir Crit Care Med 2000, 161:487-492.
6. Wasserman K, Hansen JE, Sue DY, Stringer WW, Whipp BJ. Principles of exercise testing and interpretation. 4th edition. En: Lippincott Williams and Wilkins (Eds). Baltimore: 2004. p. 2-180.
7. Oudiz R.J., Barst R.J., Hansen J.E., Sun X.G., Garofano R., Wu X., et al. Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension. Am J Cardiol 2006, 97:123-126.
8. Sun X.G., Hansen J.E., Oudiz R.J., Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 2001, 104:429-435.
9. Escribano Subías P., Jiménez C., Sáenz de la Calzada C. La hipertensión arterial pulmonar en el año 2004. Rev Esp Cardiol Supl 2005, 5:90A-103A.
10. Wensel R., Opitz C.F., Anker S.D., Winkler J., Höffken G., Kleber F., et al. Assessment of survival in patients with primary pulmonary hypertension. Circulation 2002, 106:319-324.
11. Groepenhoff H., Vonk-Noodergraf A., Boonstra A., Spreeuwenberg M., Postmus P.E., Bogaard H.J. Exercise testing to estimate survival in pulmonary hypertension. Medicine and Science in Sports and Medicine 2008, 40:1725-1732.
12. Oudiz R.J., Midde R., Hovenesyan A., Sun X.G., Roveran G., Hansen J.E., et al. Usefulness of right to left shunting and poor exercise gas exchange for predicting prognosis in patients with pulmonary arterial hypertension. Am J Cardiol 2010, 105:1186-1191.
13. Sciommer S., Badagliacca R., Fedele F. Pulmonary hypertension: echocardiographic assessment. Ital Heart J 2005, 6:840-845.
14. Bleeker G.B., Steendijk P., Holman E.R., Yu C.M., Breithardt O.A., Kaandorp T., et al. Assessing right ventricular function: the role of echocardiography and complementary technologies. Heart 2006, 92(Suppl I):92-126.
15. Sanz J., Fernández-Friera L., Moral S. Técnicas de imagen en la evaluación del corazón derecho y la circulación pulmonar. Rev Esp Cardiol 2010, 63:209-223.
16. Blyth K.G., Groenning B.A., Mark P.B., Martin T.N., Foster J.E., Steedman T., et al. NTproBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension. Eur Resp J 2007, 29:737-744.
17. Fijalkowska A., Kurzna M., Torbicki A., Szewczyk G., Florczyk M., Prusczyk M., et al. Serum NTproBNP as a prognostic parameter in patients with pulmonary hypertension. Chest 2006, 129:1313-1321.
18. Andreassen A.K., Wergelan R.W., Simonsen S., Geiran O., Guevara C., Ueland T. NTproBNP as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension. Am J Cardiol 2006, 98:525-529.
19. Díaz O., Morales A., Osses R., Klaasen J., Lisboa C., Saldías F. Prueba de marcha de 6min y ejercicio máximo en cicloergómetro en la enfermedad pulmonar obstructiva crónica, son sus demandas fisiológicas equivalentes?. Arch Bronchoneumol 2010, 46:294-301.
20. Jiménez C, Escribano P, Barberà JA, Román A, Sánchez Román J, Morales P, et al. Epidemiología de la HAP en España: análisis preliminar del Registro Español de Hipertensión Pulmonar (REHAP). [Abstract] Congreso SEC 2009. Rev Esp Cardiol; 62(Supl 3):58.
21. Humbert M., Sitbon O., Chaouat A., Bertocchi M., Habib G., Gressin V., et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010, 122:156-163.
22. Benza R.L., Miller D.P., Gomberg-Maitland M., Frantz R.P., Foreman A.J., Coffey C.S., et al. Predicting survival in pulmonary arterial hypertension. Insight from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation 2010, 122:164-172.
23. 2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest 2005, 127:1637-1646.